The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
Health Grand Rapids) and research-intensive institutions (MSU-CHM, Van Andel Research Institute) to bring basic researchers and clinicians together to create unified translational science initiatives. With
-
. The Stanford Cancer Institute Clinical Trials Office (CTO) is an integral component of the Stanford Cancer Institute since the vital work performed there enables our cancer center to translate research from
-
the integration of basic research in genetic and genomic mechanisms, translational research in disease models, and clinical trials in rare and common genetic diseases. Department-Specific Responsibilities Helps
-
opportunities, with an emphasis on patients with rare or neglected diseases. Qualified candidates will have experiences with data extraction and basic data analysis, an understanding of medical terminology, and
-
of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center for Infectious Disease (GCID) established by
-
to elucidate the genetics of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center for Infectious Disease (GCID
-
of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic Center for Infectious Disease (GCID) established by
-
engaged in moving the mission of the department, school, and university forward. The Section of Neuroradiology is seeking a full time specialized Research Professional (RP) to perform basic functions and
-
of the National Academy. Our mission is to improve the diagnosis, treatment, and basic understanding of the human disease. This is done through discovery (research), education, and clinical care. Comprised
-
Center, the Gregor Consortium to elucidate the genetics of rare disease funded by the National Human Genome Research Institute (NHGRI) and as a sequence technology core for the Texas Medical Center Genomic